GlassScriptPhysician profile
Jennifer L Burrows
NPI 1538439278
$6,362.18
in general payments reported to CMS, 2019-2025
53 companies · $875 in 2025
The $875 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,890 · 2022: $1,305 · 2023: $1,107 · 2024: $1,185 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,166.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,150.43 | 2021-2025 | |
| Novo Nordisk INC | $691.44 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $486.08 | 2021-2025 | |
| Glaxosmithkline, LLC. | $371.37 | 2021-2024 | Shingrix, Trelegy Ellipta |
| Amgen INC. | $248.27 | 2021-2023 | Evenity, Prolia |
| Lilly USA, LLC | $237.98 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.25 | 2021-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $222.98 | 2022 | |
| Exact Sciences Corporation | $183.27 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $174.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $174.24 | 2021-2023 | Seglentis, Livalo |
| Astrazeneca Pharmaceuticals LP | $171.48 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $159.12 | 2021-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $150.50 | 2021-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Amarin Pharma, INC. | $150.16 | 2021 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Burrows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.